| Literature DB >> 27820801 |
Basudeb Maji1,2,3, Christopher L Moore1,4, Bernd Zetsche1,5,6,7, Sara E Volz1,5,6,7, Feng Zhang1,5,6,7, Matthew D Shoulders1,4, Amit Choudhary1,2,3.
Abstract
Cas9-based technologies have transformed genome engineering and the interrogation of genomic functions, but methods to control such technologies across numerous dimensions-including dose, time, specificity, and mutually exclusive modulation of multiple genes-are still lacking. We conferred such multidimensional controls to diverse Cas9 systems by leveraging small-molecule-regulated protein degron domains. Application of our strategy to both Cas9-mediated genome editing and transcriptional activities opens new avenues for systematic genome interrogation.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27820801 PMCID: PMC5531067 DOI: 10.1038/nchembio.2224
Source DB: PubMed Journal: Nat Chem Biol ISSN: 1552-4450 Impact factor: 15.040